Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Candida glabrata Eukaryotic translation initiation factor 3 subunit B (PRT1), partial CSB-YP739175CZI
CSB-EP739175CZI
CSB-BP739175CZI
CSB-MP739175CZI
CSB-EP739175CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Protein CLP1 (CLP1) CSB-YP739176CZI
CSB-EP739176CZI
CSB-BP739176CZI
CSB-MP739176CZI
CSB-EP739176CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Spliceosomal protein DIB1 (DIB1) CSB-YP739177CZI
CSB-EP739177CZI
CSB-BP739177CZI
CSB-MP739177CZI
CSB-EP739177CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Arginine N-methyltransferase 2 (RMT2) CSB-YP739178CZI
CSB-EP739178CZI
CSB-BP739178CZI
CSB-MP739178CZI
CSB-EP739178CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Adenylosuccinate synthetase (CAGL0K05027g) CSB-YP739179CZI
CSB-EP739179CZI
CSB-BP739179CZI
CSB-MP739179CZI
CSB-EP739179CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Mediator of RNA polymerase II transcription subunit 11 (MED11) CSB-YP739180CZI
CSB-EP739180CZI
CSB-BP739180CZI
CSB-MP739180CZI
CSB-EP739180CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Chromatin modification-related protein EAF3 (EAF3) CSB-YP739181CZI
CSB-EP739181CZI
CSB-BP739181CZI
CSB-MP739181CZI
CSB-EP739181CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Protein SOP4 (SOP4), partial CSB-YP739182CZI
CSB-EP739182CZI
CSB-BP739182CZI
CSB-MP739182CZI
CSB-EP739182CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Topoisomerase I damage affected protein 7 (TDA7), partial CSB-YP739183CZI1
CSB-EP739183CZI1
CSB-BP739183CZI1
CSB-MP739183CZI1
CSB-EP739183CZI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata tRNA (adenine (58)-N (1))-methyltransferase non-catalytic subunit TRM6 (TRM6) CSB-YP739184CZI
CSB-EP739184CZI
CSB-BP739184CZI
CSB-MP739184CZI
CSB-EP739184CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Tubulin gamma chain (TUB4) CSB-YP739185CZI
CSB-EP739185CZI
CSB-BP739185CZI
CSB-MP739185CZI
CSB-EP739185CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Topoisomerase 1-associated factor 1 (TOF1), partial CSB-YP739186CZI
CSB-EP739186CZI
CSB-BP739186CZI
CSB-MP739186CZI
CSB-EP739186CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Probable cysteine protease ATG4 (ATG4) CSB-YP739187CZI
CSB-EP739187CZI
CSB-BP739187CZI
CSB-MP739187CZI
CSB-EP739187CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Serine/threonine-protein kinase CBK1 (CBK1), partial CSB-YP739188CZI
CSB-EP739188CZI
CSB-BP739188CZI
CSB-MP739188CZI
CSB-EP739188CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Diphthamide biosynthesis protein 2 (DPH2), partial CSB-YP739189CZI
CSB-EP739189CZI
CSB-BP739189CZI
CSB-MP739189CZI
CSB-EP739189CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Actin cytoskeleton-regulatory complex protein PAN1 (PAN1), partial CSB-YP739190CZI
CSB-EP739190CZI
CSB-BP739190CZI
CSB-MP739190CZI
CSB-EP739190CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Altered inheritance of mitochondria protein 39, mitochondrial (AIM39), partial CSB-YP739191CZI1
CSB-EP739191CZI1
CSB-BP739191CZI1
CSB-MP739191CZI1
CSB-EP739191CZI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Carbamoyl-phosphate synthase arginine-specific small chain (CPA1) CSB-YP739192CZI
CSB-EP739192CZI
CSB-BP739192CZI
CSB-MP739192CZI
CSB-EP739192CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata N-acetyltransferase ECO1 (ECO1) CSB-YP739193CZI
CSB-EP739193CZI
CSB-BP739193CZI
CSB-MP739193CZI
CSB-EP739193CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida glabrata Mediator of RNA polymerase II transcription subunit 17 (SRB4), partial CSB-YP739194CZI
CSB-EP739194CZI
CSB-BP739194CZI
CSB-MP739194CZI
CSB-EP739194CZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>